Laboratorios Farmaceuticos Rovi, S.A. (FRA:41L)
Germany flag Germany · Delayed Price · Currency is EUR
79.00
+0.50 (0.64%)
At close: Feb 20, 2026

FRA:41L Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
4,0183,2203,2131,9254,1382,099
Market Cap Growth
42.04%0.22%66.93%-53.49%97.10%55.36%
Enterprise Value
4,1033,3403,2231,9024,0662,139
Last Close Price
79.0060.9659.0534.5868.0735.21
PE Ratio
33.1623.5218.869.6427.0334.38
PS Ratio
5.554.223.872.356.385.00
PB Ratio
6.355.545.913.698.795.62
P/TBV Ratio
6.855.926.283.929.426.18
P/FCF Ratio
36.1940.6854.0410.3037.89278.47
P/OCF Ratio
23.0223.2928.378.1027.6944.79
EV/Sales Ratio
5.674.373.892.336.275.09
EV/EBITDA Ratio
22.9116.7313.547.0120.6923.87
EV/EBIT Ratio
27.2618.6914.697.5022.5728.55
EV/FCF Ratio
36.9642.2054.2210.1837.23283.73
Debt / Equity Ratio
0.200.200.120.140.160.20
Debt / EBITDA Ratio
0.690.560.270.260.360.80
Debt / FCF Ratio
1.111.451.100.390.679.87
Net Debt / Equity Ratio
0.120.150.07-0.10-0.050.06
Net Debt / EBITDA Ratio
0.430.430.17-0.19-0.130.24
Net Debt / FCF Ratio
0.671.090.67-0.28-0.242.81
Asset Turnover
0.810.940.991.010.990.77
Inventory Turnover
0.820.891.071.101.140.95
Quick Ratio
1.300.990.831.041.351.10
Current Ratio
3.023.132.552.122.662.97
Return on Equity (ROE)
20.34%24.33%31.99%40.24%36.24%17.54%
Return on Assets (ROA)
10.46%13.69%16.34%19.68%17.23%8.63%
Return on Invested Capital (ROIC)
16.98%22.00%32.24%43.00%35.96%17.16%
Return on Capital Employed (ROCE)
20.40%26.50%36.60%43.40%33.20%16.60%
Earnings Yield
3.02%4.25%5.30%10.37%3.70%2.91%
FCF Yield
2.76%2.46%1.85%9.71%2.64%0.36%
Dividend Yield
0.98%1.53%1.87%3.74%1.40%1.08%
Payout Ratio
39.48%41.24%40.54%25.55%13.80%15.89%
Buyback Yield / Dilution
-3.73%0.51%3.50%-0.03%-0.37%
Total Shareholder Return
0.98%5.26%2.38%7.24%1.37%0.71%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.